Prediagnostic 25-hydroxyvitamin D, VDR and CASR polymorphisms, and survival in patients with colorectal cancer in western european populations

Cancer Epidemiology Biomarkers and Prevention

Volumn 21, Issue 4, 2012, Pages 582-593

  Fedirko, Veronika ^a   Riboli, Elio ^b   Tjønneland, Anne ^c   Ferrari, Pietro ^a   Olsen, Anja ^c   Bueno de Mesquita, H Bas ^d,e   Van Duijnhoven, Fränzel J B ^d,f   Norat, Teresa ^b   Jansen, Eugène H J M ^d   Dahm, Christina C ^g   Overvad, Kim ^g   Boutron Ruault, Marie Christine ^h,i   Clavel Chapelon, Françoise ^h,i   Racine, Antoine ^h,i   Lukanova, Annekatrin ^j   Teucher, Birgit ^j   Boeing, Heiner ^k   Aleksandrova, Krasimira ^k   Trichopoulou, Antonia ^l,m   Benetou, Vassiliki ^l   Trichopoulos, Dimitrios ⁿ   Grioni, Sara ^o   Vineis, Paolo ^b,p   Panico, Salvatore ^q   Palli, Domenico ^r   Tumino, Rosario ^s   Siersema, Peter D ^e   Peeters, Petra H ^f   Skeie, Guri ^t   Brustad, Magritt ^t   Chirlaque, Maria Dolores ^u,v   Barricarte, Aurelio ^v,w   Quirós, Jose Ramón ^x   Sánchez, Maria José ^v,y   Dorronsoro, Miren ^z   Bonet, Catalina ^aa   Palmqvist, Richard ^ab   Hallmans, Göran ^ac   Key, Timothy J ^ad   Crowe, Francesca ^ad   Khaw, Kay Tee ^ae   Wareham, Nick ^af   Romieu, Isabelle ^a   McKay, James ^a   Wark, Petra A ^b   Romaguera, Dora ^b   Jenab, Mazda ^a   more..

^a INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c INSTITUTE OF CANCER EPIDEMIOLOGY   (Denmark)

^d NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^e UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^f WAGENINGEN UNIVERSITY   (Netherlands)

^g AARHUS UNIVERSITY HOSPITAL   (Denmark)

^h INSERM   (France)

ⁱ UNIVERSITÉ PARIS SACLAY   (France)

^j GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^k GERMAN INSTITUTE OF HUMAN NUTRITION   (Germany)

^l UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^m HELLENIC HEALTH FOUNDATION   (Greece)

ⁿ HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^o NATIONAL CANCER INSTITUTE   (Italy)

^p HuGeF Foundation   (Italy)

^q UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^r CANCER RESEARCH AND PREVENTION INSTITUTE ISPO   (Italy)

^s CIVILE M P AREZZO HOSPITAL   (Italy)

^t UNIVERSITY OF TROMSØ   (Norway)

^u DEPARTMENT OF EPIDEMIOLOGY   (Spain)

^v CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^w INSTITUTO DE SALUD PÚBLICA DE NAVARRA   (Spain)

^x Health and Health Care Services Council   (Spain)

^y ANDALUSIAN SCHOOL OF PUBLIC HEALTH   (Spain)

^z Public Health Division of Guipuzkoa   (Spain)

^aa CATALAN INSTITUTE OF ONCOLOGY   (Spain)

^ab UMEÅ UNIVERSITY   (Sweden)

^ac Nutritional Research   (Sweden)

^ad UNIVERSITY OF OXFORD   (United Kingdom)

^ae UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^af INSTITUTE OF METABOLIC SCIENCE   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYERGOCALCIFEROL; CALCIUM; CALCIUM SENSING RECEPTOR; VITAMIN D RECEPTOR;

ADULT; ARTICLE; CALCIUM INTAKE; CANCER MORTALITY; CANCER PATIENT; CANCER SURVIVAL; COLORECTAL CANCER; CONFIDENCE INTERVAL; CONTROLLED STUDY; DIET; EUROPE; FEMALE; FOLLOW UP; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HUMAN; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; VITAMIN BLOOD LEVEL;

CASE-CONTROL STUDIES; COLORECTAL NEOPLASMS; DNA; FEMALE; FOLLOW-UP STUDIES; GENOTYPE; HUMANS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; PROGNOSIS; PROSPECTIVE STUDIES; RECEPTORS, CALCITRIOL; RECEPTORS, CALCIUM-SENSING; RISK FACTORS; SURVIVAL RATE; VITAMIN D;

EID: 84859396284     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-11-1065     Document Type: Article

References (47)

1. Jenab M, Bueno-de-Mesquita HB, Ferrari P, van Duijnhoven FJ, Norat T, Pischon T, et al. Association between pre-diagnostic circulating vitamin D concentration and risk of colorectal cancer in European populations:a nested case-control study. BMJ 2010;340:b5500.
2. Wu K, Feskanich D, Fuchs CS, Willett WC, Hollis BW, Giovannucci EL. A nested case control study of plasma 25-hydroxyvitamin D concentrations and risk of colorectal cancer. J Natl Cancer Inst 2007;99:1120-9. (Pubitemid 47241396)
3. Feskanich D, Ma J, Fuchs CS, Kirkner GJ, Hankinson SE, Hollis BW, et al. Plasma vitamin D metabolites and risk of colorectal cancer in women. Cancer Epidemiol Biomarkers Prev 2004;13:1502-8. (Pubitemid 39202318)
4. Otani T, Iwasaki M, Sasazuki S, Inoue M, Tsugane S. Plasma vitamin D and risk of colorectal cancer: the Japan Public Health Center-Based Prospective Study. Br J Cancer 2007;97:446-51. (Pubitemid 47196759)
5. Garland CF, Comstock GW, Garland FC, Helsing KJ, Shaw EK, Gorham ED. Serum 25-hydroxyvitamin D and colon cancer: eight-year prospective study. Lancet 1989;2:1176-8. (Pubitemid 19275448)
6. Tangrea J, Helzlsouer K, Pietinen P, Taylor P, Hollis B, Virtamo J, et al. Serum levels of vitamin Dmetabolites and the subsequent risk of colon and rectal cancer in Finnish men. Cancer Causes Control 1997;8:615-25. (Pubitemid 27330494)
7. Braun MM, Helzlsouer KJ, Hollis BW, Comstock GW. Colon cancer and serum vitamin D metabolite levels 10-17 years prior to diagnosis. Am J Epidemiol 1995;142:608-11.
8. Woolcott CG, Wilkens LR, Nomura AM, Horst RL, Goodman MT, Murphy SP, et al. Plasma 25-hydroxyvitamin D levels and the risk of colorectal cancer: the multiethnic cohort study. Cancer Epidemiol Biomarkers Prev 2010;19:130-4.
9. Evans SR, Shchepotin EI, Young H, Rochon J, Uskokovic M, Shchepotin IB. 1,25-dihydroxyvitamin D3 synthetic analogs inhibit spontaneous metastases in a 1,2-dimethylhydrazine-induced colon carcinogenesis model. Int J Oncol 2000;16:1249-54.
10. Giuliano AR, Franceschi RT, Wood RJ. Characterization of the vitamin D receptor from the Caco-2 human colon carcinoma cell line: effect of cellular differentiation. Arch Biochem Biophys 1991;285:261-9.
11. Iseki K, Tatsuta M, Uehara H, Iishi H, Yano H, Sakai N, et al. Inhibition of angiogenesis as a mechanism for inhibition by 1alpha-hydroxyvitamin D3 and 1,25-dihydroxyvitamin D3 of colon carcinogenesis induced by azoxymethane in Wistar rats. Int J Cancer 1999;81:730-3. (Pubitemid 29214382)
12. Shabahang M, Buras RR, Davoodi F, Schumaker LM, Nauta RJ, Uskokovic MR, et al. Growth inhibition of HT-29 human colon cancer cells by analogues of 1,25-dihydroxyvitamin D3. Cancer Res 1994;54:4057-64.
13. Zhao X, Feldman D. Regulation of vitamin D receptor abundance and responsiveness during differentiation of HT-29 human colon cancer cells. Endocrinology 1993;132:1808-14. (Pubitemid 23110559)
14. Ng K, Meyerhardt JA, Wu K, Feskanich D, Hollis BW, Giovannucci EL, et al. Circulating 25-hydroxyvitamin d levels and survival in patients with colorectal cancer. J Clin Oncol 2008;26:2984-91.
15. Ng K, Wolpin BM, Meyerhardt JA, Wu K, Chan AT, Hollis BW, et al. Prospective study of predictors of vitamin D status and survival in patients with colorectal cancer. Br J Cancer 2009;101:916-23.
16. Mezawa H, Sugiura T, Watanabe M, Norizoe C, Takahashi D, Shimojima A, et al. Serum vitamin D levels and survival of patients with colorectal cancer: post-hoc analysis of a prospective cohort study. BMC Cancer 2010;10:347.
17. Heist RS, Zhou W, Wang Z, Liu G, Neuberg D, Su L, et al. Circulating 25-hydroxyvitamin D, VDR polymorphisms, and survival in advanced non-small-cell lung cancer. J Clin Oncol 2008;26:5596-602.
18. Zhou W, Heist RS, Liu G, Neuberg DS, Asomaning K, Su L, et al. Polymorphisms of vitamin D receptor and survival in early-stage non-small cell lung cancer patients. Cancer Epidemiol Biomarkers Prev 2006;15:2239-45. (Pubitemid 44877051)
19. Tretli S, Hernes E, Berg JP, Hestvik UE, Robsahm TE. Association between serum 25(OH)D and death from prostate cancer. Br J Cancer 2009;100:450-4.
20. Petrioli R, Pascucci A, Francini E, Marsili S, Sciandivasci A, De Rubertis G, et al. Weekly high-dose calcitriol and docetaxel in patients with metastatic hormone-refractory prostate cancer previously exposed to docetaxel. BJU Int 2007;100:775-9. (Pubitemid 47360167)
21. Patterson RE, Neuhouser ML, Hedderson MM,Schwartz SM, Standish LJ, Bowen DJ. Changes in diet, physical activity, and supplement use among adults diagnosed with cancer. J Am Diet Assoc 2003;103:323-8. (Pubitemid 38367642)
22. Riboli E, Hunt KJ, Slimani N, Ferrari P, Norat T, Fahey M, et al. European Prospective Investigation into Cancer and Nutrition (EPIC): study populations and data collection. Public Health Nutr 2002;5:1113-24. (Pubitemid 36313608)
23. Bingham S, Riboli E. Diet and cancer-the European Prospective Investigation into Cancer and Nutrition. Nat Rev Cancer 2004;4:206-15. (Pubitemid 38337500)
24. Jenab M, McKay J, Bueno-de-Mesquita HB, van Duijnhoven FJ, Ferrari P, Slimani N, et al. Vitamin D receptor and calcium sensing receptor polymorphisms and the risk of colorectal cancer in European populations. Cancer Epidemiol Biomarkers Prev 2009;18:2485-91.
25. Rosthoj S, Andersen PK, Abildstrom SZ. SAS macros for estimation of the cumulative incidence functions based on a Cox regression model for competing risks survival data. Comput Methods Programs Biomed 2004;74:69-75. (Pubitemid 38283682)
26. Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 2011;96:1911-30. doi:10.1210/jc.2011-0385.
27. Munger KL, Levin LI, Hollis BW, Howard NS, Ascherio A. Serum 25-hydroxyvitamin Dlevels and risk of multiple sclerosis. JAMA 2006;296:2832-8. (Pubitemid 44969183)
28. Nur U, Shack LG, Rachet B, Carpenter JR, Coleman MP. Modelling relative survival in the presence of incomplete data: a tutorial. Int J Epidemiol 2010;39:118-28.
29. Wactawski-Wende J, Kotchen JM, Anderson GL, Assaf AR, Brunner RL, O'Sullivan MJ, et al. Calcium plus vitamin D supplementation and the risk of colorectal cancer. N Engl J Med 2006;354:684-96. (Pubitemid 43247139)
30. Lamprecht SA, Lipkin M. Chemoprevention of colon cancer by calcium, vitamin D and folate: molecular mechanisms. Nat Rev Cancer 2003;3:601-14. (Pubitemid 37328832)
31. Bostick RM, Goodman M, Sidelnikov E. Calcium and vitamin D. In: Potter JD, Lindor NM, editors. Genetics of colorectal cancer. New York, NY: Springer Science + Business Media, LLC; 2009. p. 277-96.
32. Matusiak D, Murillo G, Carroll RE, Mehta RG, Benya RV. Expression of vitamin D receptor and 25-hydroxyvitamin D3-1{alpha}-hydroxylase in normal and malignant human colon. Cancer Epidemiol Biomarkers Prev 2005;14:2370-6. (Pubitemid 41437839)
33. Tangpricha V, Flanagan JN, Whitlatch LW, Tseng CC, Chen TC, Holt PR, et al. 25-hydroxyvitamin D-1alpha-hydroxylase in normal and malignant colon tissue. Lancet 2001;357:1673-4. (Pubitemid 32568244)
34. Matusiak D, Benya RV. CYP27A1 and CYP24 expression as a function of malignant transformation in the colon. J Histochem Cytochem 2007;55:1257-64. (Pubitemid 350156083)
35. Prentice A, Goldberg GR, Schoenmakers I. Vitamin D across the lifecycle: physiology and biomarkers. Am J Clin Nutr 2008;88:500S-6S.
36. Grau MV, Baron JA, Sandler RS, Haile RW, Beach ML, Church TR, et al. Vitamin D, calcium supplementation, and colorectal adenomas: results of a randomized trial. J Natl Cancer Inst 2003;95:1765-71. (Pubitemid 38008899)
37. Peters U, McGlynn KA, Chatterjee N, Gunter E, Garcia-Closas M, Rothman N, et al. Vitamin D, calcium, and vitamin D receptor polymorphism in colorectal adenomas. Cancer Epidemiol Biomarkers Prev 2001;10:1267-74. (Pubitemid 34027758)
38. Oh K, Willett WC, Wu K, Fuchs CS, Giovannucci EL. Calcium and vitamin D intakes in relation to risk of distal colorectal adenoma in women. Am J Epidemiol 2007;165:1178-86. (Pubitemid 47233720)
39. Levine AJ, Harper JM, Ervin CM, Chen YH, Harmon E, Xue S, et al. Serum 25-hydroxyvitamin D, dietary calcium intake, and distal colorectal adenoma risk. Nutr Cancer 2001;39:35-41. (Pubitemid 32880946)
40. Ebert R, Schutze N, Adamski J, Jakob F. Vitamin D signaling is modulated on multiple levels in health and disease. Mol Cell Endocrinol 2006;248:149-59.
41. McCullough ML, Bostick RM, Mayo TL. Vitamin D gene pathway polymorphisms and risk of colorectal, breast, and prostate cancer. Annu Rev Nutr 2009;29:111-32.
42. Touvier M, Chan DS, Lau R, Aune D, Vieira R, Greenwood DC, et al. Meta-analyses of vitamin D intake, 25-hydroxyvitamin D status, vitamin D receptor polymorphisms and colorectal cancer risk. Cancer Epidemiol Biomarkers Prev 2011;20:1003-16.
43. Jenab M, McKay J, Bueno-de-Mesquita HB, van Duijnhoven FJ, Ferrari P, Slimani N, et al. Vitamin D receptor and calcium sensing receptor polymorphisms and the risk of colorectal cancer in European populations. Cancer Epidemiol Biomarkers Prev 2009;18:2485-91.
44. Tamez S, Norizoe C, Ochiai K, Takahashi D, Shimojima A, Tsutsumi Y, et al. Vitamin D receptor polymorphisms and prognosis of patients with epithelial ovarian cancer. Br J Cancer 2009;101:1957-60.
45. Kapur K, Johnson T, Beckmann ND, Sehmi J, Tanaka T, Kutalik Z, et al. Genome-wide meta-analysis for serum calcium identifies significantly associated SNPs near the calcium-sensing receptor (CASR) gene. PLoS Genet 2010;6:e1001035.
46. Friedenreich C, Cust A, Lahmann PH, Steindorf K, Boutron-Ruault MC, Clavel-Chapelon F, et al. Physical activity and risk of endometrial cancer: the European prospective investigation into cancer and nutrition. Int J Cancer 2007;121:347-55. (Pubitemid 46917704)
47. Velicer CM, Ulrich CM. Vitamin and mineral supplement use among US adults after cancer diagnosis: a systematic review. J Clin Oncol 2008;26:665-73. (Pubitemid 351264364)